Biomedical Research

The current era of the COVID-19 pandemic has focused on many problems that have been less discussed for a nexus, like the control of Non-Communicable Diseases (NCD). In the 21st century, the NCDs became the subject of debate and a major challenge to public health as it extended its impact internationally from developed countries to the world's low and middle-income nations. Individuals with NCDs such as Diabetes, Hypertension, Coronary, Nephritic, Cerebrovascular disorders, and others are more susceptible to acquiring communicable diseases such as COVID-19, as their health and immunity are impaired by chronic diseases. Their co-occurrence normally leads to greater severity and even early patient mortality. The COVID-19 era challenged the departments of government and public health to consider and manage the crucial intersection of infectious diseases and chronic non-communicable diseases. This nexus is important to consider, as evidence from different countries with the increased COVID-19 burden has shown that patients with underlying chronic diseases have suffered, received critical care, and died when impacted with COVID-19.

Author(s): Maanasa R
Abstract | Full-Text | PDF

Share this